Video

Hidden Costs for Patients Starting a Specialty Drug Regimen

Author(s):

Lauren Santye, Assistant Editor

Marc O'Connor, COO and chief strategy officer at Curant Health, discusses the out-of-pocket costs that can emerge for patients starting a specialty medication regimen.

Marc O'Connor, COO and chief strategy officer at Curant Health, discusses the out-of-pocket costs that can emerge for patients starting a specialty medication regimen.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Related Content
In Control Room Doctor and Radiologist Discuss Diagnosis while Watching Procedure and Monitors Showing Brain Scans Results, In the Background Patient Undergoes MRI or CT Scan Procedure.
June 27th 2025

Chronic IVIG Therapy May Reduce Incidence of Cancer, Especially in Patients With CIDP

Luke Halpern, Assistant Editor
Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder
March 31st 2025

Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder

Luke Halpern, Assistant Editor
Water coming from a faucet - Image credit: Ajax9 | stock.adobe.com
June 25th 2025

Is Fluoride Friend or Foe?

Jim Ruble, PharmD, JD
Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education
February 28th 2025

Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education

Luke Halpern, Assistant Editor Jill Simonian, PharmD Codi Peterson, PharmD, MS
Patient with oral chemotherapy -- Image credit: Beaunitta Van Wyk/peopleimages.com | stock.adobe.com
June 23rd 2025

Understanding Recent Changes to 505(b)(2) Drugs and Reimbursement

Alana Hippensteele, Lead Editor
FDA Approves Dupilumab for Treatment of Bullous Pemphigoid
June 20th 2025

FDA Approves Dupilumab for Treatment of Bullous Pemphigoid

Aislinn Antrim, Managing Editor